Lada Nuzhna

11 statements across 1 episodes · 4 bullish · 2 bearish · 1 people on the record · first statement Nov 14, 2025 by Lada Nuzhna · across every show →

On the record as a speaker too: Lada Nuzhna's record, appearances and statements → this page counts the times other people say the name.

Everything said about Lada Nuzhna, oldest first

Nov 14, 2025 positive

Insight

Nuzhna: Biological breakthroughs stem from new modalities, not target discoveries

“Every time I think about where the biggest breakthroughs and successes in biology came from, it was always served from some type of technology or process or technique and rarely from like discovering a new target.”

Lada Nuzhna Nov 14, 2025 ▶ 55:01 The Brutal Truth About Biotech: Why $2B Per Drug Is Killing Innovation

Nov 14, 2025 bullish

Prediction Not checkable as stated

Nuzhna: Medicine will treat aging before understanding its underlying mechanisms

“I think we would be able to treat aging before we understand how to measure it or what it is or why it happens.”

Lada Nuzhna Nov 14, 2025 ▶ 40:24 The Brutal Truth About Biotech: Why $2B Per Drug Is Killing Innovation

Nov 14, 2025 bullish

Assertion Not checkable as stated

Nuzhna: Modern medical stack can eliminate heart attacks for current generation

“And it does seem like we kind of hit a point where actually like our generation shouldn't die of heart attacks. It seems like we have everything to prevent high cholesterol in people from, like you can take antibodies sRNAs, small molecules, sun gene editors. …”

Lada Nuzhna Nov 14, 2025 ▶ 41:45 The Brutal Truth About Biotech: Why $2B Per Drug Is Killing Innovation

Nov 14, 2025

Insight

Nuzhna: Biotech companies should avoid being contrarian on novel biological mechanisms

“And I think biology is like one of the areas where you really don't want to be contrarian. You don't want to be the only company pursuing some obscure mechanism. Usually you want to have some literature validation, but in both of these cases, it was either a b…”

Lada Nuzhna Nov 14, 2025 ▶ 53:57 The Brutal Truth About Biotech: Why $2B Per Drug Is Killing Innovation

Nov 14, 2025 neutral

Assertion Supported

Nuzhna: Phase 2 efficacy trials have the highest drug development failure rate

“The highest failure rate right now is phase two, which is efficacy.”

Lada Nuzhna Nov 14, 2025 ▶ 25:01 The Brutal Truth About Biotech: Why $2B Per Drug Is Killing Innovation

Nov 14, 2025 negative

Opinion

Nuzhna: Treating aging with existing modalities is an uphill battle

“I think aging is in a somewhat similar space in that it's a massive multifactorial disease, and if we rely on existing modality approaches, it would just be an uphill battle to try and treat it.”

Lada Nuzhna Nov 14, 2025 ▶ 55:36 The Brutal Truth About Biotech: Why $2B Per Drug Is Killing Innovation

Nov 14, 2025 bullish

Prediction Not checkable as stated

Nuzhna: AI virtual cell models are near realization with existing data

“Virtual cells is actually not that far out. I think we have all the necessary data to generate something like that.”

Lada Nuzhna Nov 14, 2025 ▶ 25:33 The Brutal Truth About Biotech: Why $2B Per Drug Is Killing Innovation

Nov 14, 2025 neutral

Prediction Not checkable as stated

Nuzhna: AI will solve open biology questions before predicting drug efficacy

“Many big bio problems and open questions will be solved with AI way before we can predict efficacy for drugs.”

Lada Nuzhna Nov 14, 2025 ▶ 25:23 The Brutal Truth About Biotech: Why $2B Per Drug Is Killing Innovation

Nov 14, 2025 neutral

Assertion Supported

Nuzhna: Caloric restriction is only proven lifespan extender in monkeys

“The only documented effect for lifespan that we have in monkeys is caloric restriction. We know that we can add about two and a half years to 25 year median lifespan in monkeys by calorically restricting them.”

Lada Nuzhna Nov 14, 2025 ▶ 42:35 The Brutal Truth About Biotech: Why $2B Per Drug Is Killing Innovation

Nov 14, 2025 negative

Assertion Partly supported

Nuzhna: Lifespan-extending drugs in animals remain untested in humans

“I think regulation is lagging behind science. I think we have multiple drugs that extend lifespan in mice and monkeys that never been tested for lifespan indications in humans.”

Lada Nuzhna Nov 14, 2025 ▶ 39:57 The Brutal Truth About Biotech: Why $2B Per Drug Is Killing Innovation

Nov 14, 2025 neutral

Assertion Supported

Nuzhna: Preclinical spending is a minor portion of drug development cost

“Most of it's spent is not in preclinical stage. It's spent in validating safety and efficacy in humans. It's spent on commercialization stage, which is what happens after phase three clinical trials.”

Lada Nuzhna Nov 14, 2025 ▶ 24:21 The Brutal Truth About Biotech: Why $2B Per Drug Is Killing Innovation

Lada Nuzhna

Everything said about Lada Nuzhna, oldest first

Turn any episode into a week of clips.